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Abstract: The reaction mechanism of the carbonic anhydrase-
mediated hydrolysis of sulfocoumarins to sulfonic acids has been 
investigated on an enzyme cluster model using the B3LYP hybrid 
density functional theory (DFT) and the QST procedure for the 
Transition State (TS) search. A multistep process was highlighted, 
with the rate determining step identified in the initial dual 
nucleophilic/acidic attack of the zinc bound-hydroxide ion to the 
sulfocoumarin sulfur atom and to the C3-C4 double bond. The 
reported multi-step process, combined to SAR analysis on a new set 
of derivatives, highlighted unprecedentedly considered mechanistic 
aspects of the CA-mediated prodrug activation, which in turn do 
possess relevant consequences to the isoforms-selective inhibition 
profiles reported by such a class of compounds. 
The discovery of the coumarin bioisosters 1,2-
benzoxathiine-2,2-dioxides, also named sulfocoumarins, as 
novel and selective inhibitors of the zinc metalloenzymes α-
carbonic anhydrases (CAs, EC 4.2.1.1) is the result of 
intense efforts towards the development of innovative 
compounds as potential tools for the treatment of various 
diseases.[1-4] The role of CAs in cells as well as in complex 
organisms, is primarily related to their ability to reversibly 
catalyze the carbon dioxide hydration reaction to afford 
bicarbonate and a proton.[5,6] Such an equilibrium is crucial 
for a vast array of physio/pathological processes.[5-7] The 
CA mediated catalytic pathway proceeds at first with the 
nucleophilic attack of a Zn2+-bound hydroxide ion towards 
the CO2 substrate with consequent formation of a CA-
HCO3− adduct, which is then displaced from the active site 
by an additional water molecule. The final, rate limiting step, 
regenerates the catalytically active Zn2+-bound hydroxide 
ion by means of a proton transfer reaction from the Zn2+-
bound water molecule to an external proton acceptor or to 
an active site residue.[7] 
Besides the hydration on CO2, some CAs are endowed with 
a certain substrate versatility, which includes COS, CS2 
cyanamides and aldehydes hydration reactions.[5] α-CAs 
are also reported to possess hydrolytic activities towards 
esters of carboxylic acids, sulfonic acids, phosphates and 
thioesters.[5,8]  
The esterase activity shown by the α-CAs, was the 
enzymatic blueprint which allowed us to make use of 
prodrugs of the coumarin and sulfocoumarin type as novel 
classes of CA Inhibitors (CAIs).[1,9-12] In analogy to the 
coumarins, the sulfocoumarins are not per se able to inhibit 
the CA activity. Instead they interfere with the enzyme by 
acting as efficient substrates for the esterase (sulfatase) 
activity, generating the actual inhibitor in situ.[1-3] Thereafter 
the formed sulfonic acid inhibit the enzyme by means of a 
stable adduct and a particular inhibition mechanism, i.e., 
anchoring to the non-protein zinc ligand.[1-3] The prodrug 
features of the sulfocoumarin scaffold was also consistent
 
Figure 1. A) Structure of the 6-bromosulfocoumarin; B) The corresponding 
sulfonic acid was obtained from in situ hydrolysis and binds into the hCA II/IX 
mimic active site, by anchoring of the sulfonic acid group to the zinc-
coordinated water molecule (PDB 4BCW).[1] 
with the longer time of incubation required to exert in vitro 
inhibition against the α-CAs (6h vs 15 minutes for the 
classical zinc binders CAIs of the sulfonamide type).[1,9,12] 
Evidences for the CA promoted intramolecular sulfonic 
ester cleavage was obtained by means of X-ray co-
crystallographic experiments conducted by soaking a hCA 
II/IX mimic isoform with the 6-bromo-sulfocoumarin 1 
(Figure 1).[1] 
The 2Fo–Fc density maps showed a well-defined density for 
the in situ formed sulfonate, which anchors to the Zn-bound 
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water within the hCA II/IX mimic active site.[1] The adduct is 
further stabilized by means of a network of hydrogen bonds 
occurring between the ligand and the Pro202/Thr200 amino 
acid residues from the enzyme active site.[1] 
To date a detailed reaction mechanism for the CA-mediated 
intramolecular sulfonic esters hydrolysis has not yet been 
reported. In recent studies, we investigated a variety of 
sulfocoumarins bearing electro-withdrawing (EWG) or 
electro-donating (EDG) groups placed at the 6- and 7- 
position.[1-3,13,14] Herein, as extension of our previous 
investigations, we report novel analogues decorated at the 
6- and 7-position with chemical moieties endowed with 
different electronic properties (EWG and EDG, scheme 1) 
and their inhibition profiles against the most relevant human 
(h)CAs are reported. Since computational studies are 
validated tools to provide deep insights into enzymatic 
mechanisms,[15-20] we made use of the B3LYP hybrid 
density functional theory (DFT) to study the hydrolysis of 
the unsubstituted sulfocoumarin (compound 10 – scheme 
1) upon the CA-esterase activity, by using the X-Ray crystal 
structure of CA II/IX mimic in complex with the hydrolysed 
6-bromosulfocoumarin as a model. 
The novel sulfocoumarins 10-14 were obtained by applying 
the general synthetic strategy firstly reported by 
Zalubovski’s group (Scheme 1).[4,13]  
 Scheme 1. General synthetic procedure of sulfocoumarins 10-14. 
Reaction of the proper 2-hydroxybenzaldehydes 1-3 with 
mesyl chloride afforded the mesylate derivates 4-6, which 
were treated with 1,8-diazabicyclo[5.4.0]undec-7-ene 
(DBU), with formation of the racemic 4-hydroxy-3,4-
dihydrosulfocoumarins 7-9 in mixture with their dehydration 
products 10-12 The dehydration was further pushed 
forwards by treating the mixtures with POCl3 in pyridine. 7-
NH2-sulfocoumarin 13 was obtained by reducing the 
correspondent nitro-derivative 12 with iron (0), which in turn 
was converted to the chlorine compound 14 through 
Sandmeyer reaction with CuCl2 in the presence of tert-butyl 
nitrite. 
The final compounds 10-14 were screened in vitro for the 
inhibition against four physiologically relevant hCA 
isoforms, the cytosolic hCAI and II and the trasmembrane 
tumor-associated hCAIX and XII.  
Table 1: Inhibition data of hCA isoforms I, II, IX and XII with sulfocoumarins 10-
14 compared to the standard sulfonamide inhibitor acetazolamide (AAZ) by the 
stopped flow CO2 hydrase assay.[21] 
  
 KI (nM)a 
Cmp R hCA I hCA II hCA IX hCA XII 
10 H >100000 >100000 432.2±33.1 69.5±5.1 
Ab 6-NO2 92000±4800 >100000 3770±240 3160±210 
Bc 6-NH2 6780±560 8890±710 46.0±3.1 23.0±1.2 
11 6-Cl >100000 >100000 136.3±7.5 89.5±5.4 
12 7-NO2 >100000 >100000 37.0±2.1 81.7±4.3 
13 7-NH2 >100000 >100000 33.5±1.9 38.4±2.2 
14 7-Cl >100000 >100000 33.7±1.8 60.9±4.6 
AAZ - 250±15 12±0.8 25±1.4 5.7±0.5 
a. Inhibition data are expressed as means ± SEM of 3 different assays; b. 
compound 10 in ref. 1; c. compound 11 in ref. 1. 
The following Structure-Activity-Relationships (SARs) can 
be draw from the inhibition data of Table 1:  
(i) In agreement with previous literature reports,[1-4] the 
sulfocoumarins 10-14 were ineffective in inhibiting the 
isoform hCA I and II. The only exception was the compound 
B which was effective against both cytosolic isoforms at low 
micromolar concentrations (KIs 6780±560 and 8890±710 
μM respectively). 
(ii) The transmembrane hCA isoforms resulted inhibited by 
the sulfocoumarins here reported, with KI values spanning 
between 33.5±1.9 - 3770±240 nM and 23.0±1.2 - 3160±210 
nM against the hCA IX and hCA XII respectively. The 
introduction of substituents of the NO2 or NH2 type on the 6 
position of the sulfocoumarin ring, as in A and B, 
 
Figure 2. Superimposition of the docked pose of sulfocoumarin 10 (blue) 
and the hydrolized form of 6-bromosulfocoumarin (black) in hCA II/IX 
mimic active site (4BCW).  
 






Figure 3. A. Reaction path for step I. Thr199 omitted for clarity; B. Drawings of the resonant structures for II. Zinc coordination bon ds are represented 
as hashed lines; C. Energy profile for the calculated multi-step reaction path of the unsubstituted sulfocoumarin CA-mediated hydrolysis. Red dashed 
lines represent reaction energies, black dashed lines activation energies (energy values in kcal/mol).
led to opposite changes in the hCA IX and XII inhibitory 
properties in comparison to the unsubstituted 10 (KIs of 
432.2±33.1 and 69.5±5.1 nM, respectively). Indeed, A 
inhibit both isozymes with KIs ranging between 3160±210 
and 3770±240 nM, whereas B exhibited enhanced 
inhibition profiles in the range 23.0±1.2 - 46.0±3.1 nM. 
Among 7-substituted derivatives, all functionalizations do 
increase hCA IX inhibition potency with respect to 10, with 
hCA XII being instead more significantly affected uniquely 
in the case of 13 (7-NH2, KI of 38.4±2.2 nM). 
The cluster-based approach was considered to overcome 
the complexity in treating the overall enzyme systems with 
the quantum-mechanical (QM) transition state search 
methods.[17-19] It is worth stressing the importance of the 
identification of a proper cluster model, which was 
propaedeutical to unveil the reaction mechanism.[17-19] 
Indeed, considering that the differently substituted 
sulfocoumarins possessed diverse activity on the CA 
isoforms, we had to look for the common elements deemed 
to be involved in the esterase process among the different 
isozymes, whose active site cavities differ for residues 
composition and molecular architectures.[5,7,22] As a result, 
these latter define lightly narrower binding pockets for hCA 
I, II in comparison to hCA IX and XII.[22] 
Thus, a model of the active site was built using the PDB 
4BCW coordinates, which includes the essential parts 
involved in the reaction: (i) the Zn ion; (ii) the Zn-bound OH- 
(as present in the active form of the enzyme); (iii) three 
imidazole rings representative of the three side chains of 
the His residues; (iv) the truncated Thr199 residue, that in 
the crystal structure established a H-bond with the sulfonate 
moiety, and (v) an additional water molecule extrapolated 
from the X-ray structure. In the crystal structure, the 
hydrolysed 6-substituted sulfocoumarin locates its sulfonate 
oxygen 2.8 Å apart from the Zn ion. The unsubstituted 
sulfocoumarin 10 was considered as the best candidate to 
initially identify the steps through which the process takes 
place, owing to minor electronic effects by absence of 
appended substituents. Compound 10 was docked into the 
4BCW active site (Figure 2), and subsequently the complex 
was superposed with the built cluster model to obtain the 
starting position of 10 into the model system. The transition 
state (TS) search undertaken (ESI, Theoretical studies) 
highlighted the presence of a multi-step process (Figure 3). 
(i) In the optimized docked pose of the sulfocoumarin 10 
within the cluster model (I, cfr ESI for the procedure used to 
obtain the I, II and TS I systems, i.e. adduct, structures), the 
distance between the negative oxygen atom of the Zn-
bound hydroxide ion and the sulfonate ester sulfur atom 
was of 3.87 Å (Figure 3A). Such a distance makes the 
hydroxide ion suitable to elicit a nucleophilic attack towards 
the electrophilic sulfonic ester, thus inducing the cycle to 
open by lengthening the distance between sulfur and the 
endocyclic oxygen. At the same time the hydroxide 
hydrogen protonates the double bond of the forming 
ethenylsulfonic acid, with the formation of the stable 
carbocation locating the positive charge on C4 of the 
starting sulfocoumarin. The simultaneous occurring of these 
two events provides the molecule with the degree of  






Figure 4. Reaction path for steps II, III and IV. Thr199 omitted for clarity. Intermediate III reported as III (H 2O) for clarity. 
 
freedom necessary to rearrange, leading to the first reaction 
intermediate (II). The bond lengths featuring II, are 
consistent with its stabilization by means of two main 
resonance structures of the carbocation and the phenoxide 
ion type (Figure 3B). The activation barrier for the first step 
was 36.8 kcal/mol (Figure 3C).  
(ii) The second step pertains the Z to E isomerization 
(Figure 4). In this step an intramolecular acid-base reaction 
occurs, where the phenoxide moiety acts as a base to 
deprotonate the CH2 moiety (C3 position of the starting 
sulfocoumarin 10). As for step (i), also here a simultaneous 
intramolecular rearrangement takes place, providing the 
less hindered isomer E (III). Overall, the II → III reaction 
energy is -7.4 kcal/mol (Figure 3C), while the activation 
barrier is 16.1 kcal/mol. 
(iii) As known, the displacement of a zinc-bound ligand in 
the enzyme active site proceeds through the so-called 
water-exchange pathway.[5] Thus, an additional water 
molecule was added to III (ESI, Theoretical Studies). The 
observed TS evidences that the added water molecule 
approaches the Zn ion, eliciting a reorganization of the 
coordination sphere, by which a trigonal bipyramid is 
formed having the sulfonate oxygen, and its opposite 
histidine nitrogen in apical positions (Figure 4). The 
activation barrier is only 0.4 kcal/mol (Figure 3C).  
(iv) Finally, the sulfonate moiety slightly moves away from 
the Zn ion and the remaining components of the trigonal 
bipyramid rearrange forming a pseudo tetrahedrical 
coordination system (Figure 4). The activation barrier for 
this step was 9.8 kcal/mol. The anchoring of the sulfonate 
to the zinc coordinated water molecule is expected to 
prevent its deprotonation and, as a consequence, the 
restoring of the zinc bound hydroxide ion. Noteworthy, it 
should be mentioned that in the native CA II crystal 
structure (PDB 2CBA)[23] a zinc-bound water molecule has 
been observed.  
The energy profile shown in Figure 3C evidences that 
product V is thermodynamically unstable with respect to its 
precursor IV by 7.3 kcal/mol. These data are in agreement 
with the cluster model herein considered where the 
bipyramidal coordination of IV is expected to prevail on the 
pseudo tetrahedral one of V. Nevertheless, it is noteworthy 
that even in the 4BCW adduct, the coordination geometry of 
the zinc ion is actually better described as a distorted 
tetrahedron rather than as a trigonal bipyramid, with an 
oxygen atom from the hydrolysed inhibitor at only 2.8 Å 
from the metal centre. Indeed, the relative instability 
ascribed to the pseudo-trigonal bipyramid coordination 
pattern found for the adduct IV is compensated by 
additional non-bonded interactions (i.e. H-bonds and 
hydrophobic contacts) occurring between the ligand and the 
amino acid residues of the enzymatic cleft, thus contributing 
to further stabilize the orientation assumed by the ligand 
(Figure 2). 
In conclusion, our theoretical model indicated the first step, (i.e. 
the nucleophilic attack of the zinc-hydroxide ion on the cyclic 
sulfonate), as the rate-determining step for the entire hydrolytic 
reaction. This finding is not surprising, as the cycle opening and 
the overall ligand rearrangement required a dual attack of the 
zinc-bound O-H group both to the sulfocoumarin sulfur atom and 
to the C3-C4 double bond. Structure-activity-relationship (SAR) 
analysis based on the obtained inhibition assay was rather flat. 
We propose that the CA isoform-selective inhibition of 
sulfocoumarins may be properly ascribed to the mechanism 





through each α-CA hydrolyzes different substrates rather to 
depend from conventional enzyme-ligand interactions occurring 
between the amino acids of the enzymatic cleft and the product 
obtained from the hydrolytic process. In this context, it is 
reasonable to hypothesize that the ligand rearrangements 
described in the reaction mechanism (cluster model) strictly 
depend on the active sites architectures when taking place 
within the overall binding cavities. As a results, the overall 
molecular architectures as well as the different isoforms binding 
site residues could allow or impair the hydrolytic process, with 
the roomier active site of hCA IX and XII in comparison to hCA I 
and II being more suitable to accommodate the ligand 
rearrangements required to start and complete the process.[5,7,22] 
Therefore, the knowledge of such mechanism might further aid 
in the design of novel specific enzymatic modulators and 
currently further studies are ongoing in this direction.  
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